Blood Pressure Medication Prevents Myelin Damage and Reduces MS-like Symptoms in Mice
March 13, 2015
Researchers at the University of Chicago report that the blood pressure medication guanabenz increases the survival of myelin-making cells and reduces symptoms in MS-like disease in mice. First author Sharon Way, PhD, was funded in this work by a postdoctoral fellowship from the National MS Society, supported in part by the Dave Tomlinson Research Fund. The medication is now being tested for its potential to treat people with MS.
Read more on Medical Xpress.
Read the study, reported in Nature Communications.
Read more about research to repair damage in MS.